Hepatocyte growth factor administration increases bone soluble phosphate and alters bone chemical structure in diabetic hypertensive rats
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Materials Research"
DOI: 10.1557/s43578-021-00300-8
Abstract: Hepatocyte growth factor (HGF) is a novel potential therapy for improving bone health in patients with type II diabetes and hypertension, but its effect on the bone molecular structure is not revealed yet. Here, X-ray… read more here.
Keywords: diabetic hypertensive; structure; bone chemical; growth factor ... See more keywords